[HTML][HTML] Ketogenic diet in Alzheimer's disease
M Rusek, R Pluta, M Ułamek-Kozioł… - International journal of …, 2019 - mdpi.com
At present, the prevalence of Alzheimer's disease, a devastating neurodegenerative
disorder, is increasing. Although the mechanism of the underlying pathology is not fully …
disorder, is increasing. Although the mechanism of the underlying pathology is not fully …
[HTML][HTML] Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance
Alzheimer's disease (AD) is the most common form of dementia. AD brain pathology starts
decades before the onset of clinical symptoms. One early pathological hallmark is blood …
decades before the onset of clinical symptoms. One early pathological hallmark is blood …
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models
The goal of this review is to discuss how behavioral tests in mice relate to the pathological
and neuropsychological features seen in human Alzheimer's disease (AD), and present a …
and neuropsychological features seen in human Alzheimer's disease (AD), and present a …
Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
M Pajares, N Jiménez-Moreno, ÁJ García-Yagüe… - Autophagy, 2016 - Taylor & Francis
Autophagy is a highly coordinated process that is controlled at several levels including
transcriptional regulation. Here, we identify the transcription factor NFE2L2/NRF2 (nuclear …
transcriptional regulation. Here, we identify the transcription factor NFE2L2/NRF2 (nuclear …
Cathepsin B gene knockout improves behavioral deficits and reduces pathology in models of neurologic disorders
G Hook, T Reinheckel, J Ni, Z Wu, M Kindy… - Pharmacological …, 2022 - ASPET
Cathepsin B (CTSB) is a powerful lysosomal protease. This review evaluated CTSB gene
knockout (KO) outcomes for amelioration of brain dysfunctions in neurologic diseases and …
knockout (KO) outcomes for amelioration of brain dysfunctions in neurologic diseases and …
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
M Willem, S Tahirovic, MA Busche, SV Ovsepian… - Nature, 2015 - nature.com
Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are
predominantly composed of amyloid-β peptide. Two principal physiological pathways either …
predominantly composed of amyloid-β peptide. Two principal physiological pathways either …
The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization
IW Hamley - Chemical reviews, 2012 - ACS Publications
This review is concerned with the role of fibrillization of the amyloid β (Aβ)-peptide in
Alzheimer's disease (AD). The perspective is that of a physical chemist, and one aim is to …
Alzheimer's disease (AD). The perspective is that of a physical chemist, and one aim is to …
Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease
Alzheimer's disease (AD) is characterized by a progressive dysfunction of central neurons.
Recent experimental evidence indicates that in the cortex, in addition to the silencing of a …
Recent experimental evidence indicates that in the cortex, in addition to the silencing of a …
Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer's mouse model
C Brandscheid, F Schuck, S Reinhardt… - Journal of …, 2017 - content.iospress.com
The regulation of physiological gut functions such as peristalsis or secretion of digestive
enzymes by the central nervous system via the Nervus vagus is well known. Recent …
enzymes by the central nervous system via the Nervus vagus is well known. Recent …
Protein misfolding, functional amyloid, and human disease
Peptides or proteins convert under some conditions from their soluble forms into highly
ordered fibrillar aggregates. Such transitions can give rise to pathological conditions ranging …
ordered fibrillar aggregates. Such transitions can give rise to pathological conditions ranging …